“Just-in-Time” trials are designed to be opened easily and quickly at any site as soon as researchers identify an eligible patient. This trial strategy differs from a traditional clinical trial, in which trial sites are identified and opened before researchers begin enrolling patients.
“Just-in-Time” trials reduce the time and cost of setting up clinical trials and help people with rare cancer mutations enter a trial quickly. Read below to learn about the “Just-in-Time” approach, how it works, and how it benefits both patients and investigators.
The Benefits of Just-in-Time Trials
- Medscape: New Options for Rare Cancer Mutations: Basket and ‘Just-in-Time’ Trials (Video)
- American Journal of Managed Care: Dr. Michael Kolodziej on How Technology Will Improve Patient Access to Clinical Trials (Video)
- Journal of Clinical Oncology: Revolutionizing Oncology Patient Enrollment in Clinical Trials: Just-in-Time Approach
- PharmTech: Necessity Drives Just-in-Time Approaches to Clinical Trials Supply
- Clinical Research News: New Clinical Trial Models Make Studies An Option For More People
How It Works
- Foundation Medicine: Accelerating Clinical Trial Enrollment with Comprehensive Genomic Profiling (CGP) and “Just-in-Time” Clinical Trial Sites
- Syneo Health: Just-in-Time Site Activation
Journal Article
- Drug Information Journal: A Patient-Focused Solution for Enrolling Clinical Trials in Rare and Selective Cancer Indications: A Landscape of Haystacks and Needles
Last Modified on April 5, 2021